MentionFox
Home › funding signals › Cardiosense, Inc.
Form D · on the record

Cardiosense — $26.14M Form D filing, August 2026

Cardiosense, Inc. filed a Form D with the Securities and Exchange Commission on 2026-08-24.

Cardiosense, Inc. filed a Form D notice of an exempt securities offering with the SEC on August 24, 2026. The filing reports $26.14M sold. Its industry group is Other Health Care. It names Eric Meizlish (Executive Officer, Director), Andrew Carek (Executive Officer), Daniel Gottlieb (Director) (SEC Form D, August 24, 2026).

In its own words: “CardioTag™ is the world's first noninvasive device delivering PCWP at point-of-care, enabling clinicians to precisely manage Heart Failure patients.” (cardiosense.com, checked October 31, 2026)

125 companies raised this week.

Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.

Andersen Aggregator LLC$1.9BBusiness services
AT Umbrella LLC$1.9BBusiness services
Legora, Inc.$221MAI and software
MD INVESTMENT LLC$169MBusiness services
Serval Inc.$149MAI and software
Check one company free

5 more Other Health Care raises in Illinois within 90 days ↓

Selling to Cardiosense, Inc.? See who runs it and how to reach them, plus this week's 25 other newly funded companies.

Is this your company?

Key facts

Run the free check on Cardiosense, Inc. →

Sell to companies like Cardiosense, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.

Opens in a new tab. No signup.

Cardiosense, Inc.

New Form D on file · 2026-08-24 · the record

$26.14M
raise on the record
D
filing
30
investors in
ILLINOIS
based
Open the record →

What the record says

FilingForm D
Filed2026-08-24
Industry groupOther Health Care
Entity typeCorporation
Incorporated inDELAWARE
BasedCHICAGO, ILLINOIS
CIK1957335
Accession0001957335-26-000003

Pitching, partnering or investing alongside them? See who really runs and owns Cardiosense, Inc.

Free to see. No signup.

Keep reading

More on the people and the money behind Cardiosense, Inc., from the filings we hold.

More raises like this

Other Health Care raises by companies based in Illinois, filed within 90 days of this one, largest first.

What do you want to do with Cardiosense, Inc.?

Get the full cited report on Cardiosense, Inc.

What the filing shows about Cardiosense, Inc.

  • 30 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Cardiosense, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

See a sample report

Who the filing names, and in what role

The filing gives Cardiosense, Inc.'s address as 400 N. Aberdeen St., Suite 1050, Chicago, IL 60642.

What the filing says

  • Offered: $42,012,230. Sold: $26,137,050. Left to sell: $15,875,180. (filing)
  • Investors: 30 had already invested. (filing)
  • Date of first sale: August 7, 2026. (filing)
  • Types of securities: Equity; Securities to be acquired on exercise of an option, warrant or other right; Other: Convertible Promissory Notes have converted into equity in connection with this transaction. (filing)
  • Item 16: the filing reports that none of the proceeds goes to executive officers, directors or promoters. (filing)

This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.

Order the Full Report on Cardiosense, Inc. See pricing

Is Cardiosense, Inc. a real, registered company?

Cardiosense, Inc. is a registered filer with the SEC (CIK 1957335) and has filed since 2022-12-09. 2 filings are on record, the latest on 2026-08-24.

A filing shows the company exists and what it reports about itself. It is not an audit or a rating.

Who runs Cardiosense, Inc.?

Cardiosense, Inc.'s Form D of 2026-08-24 names Eric Meizlish, Andrew Carek, Daniel Gottlieb and 4 more as its officers, directors or promoters.

How much has Cardiosense, Inc. raised?

Its new offerings report $35.22M sold across 2 offerings, as its own filings state.

Filing history · 2 filings on this registrant
Form D · 2022-12-09 · $9.08MForm D · 2026-08-24 · $26.14M · this page 2022-12-09 2026-08-24

Each marker is one filing. The larger marker is the filing this page is about.

Other Health Care · by week
This raise, $26.14M, filed week of Aug 24

Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $26.14M, on the same scale — one filing against the whole group's total, so it sits low by construction.

Want the whole picture on Cardiosense, Inc.?

What the filing shows about Cardiosense, Inc.

  • 30 investors had already put money in when it filed.
  • The filing names 7 people as officers, directors or promoters.

Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.

Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC

A Full Report on Cardiosense, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.

What the Full Report on Cardiosense, Inc. covers

  1. The Short Answer

  2. Which Company This Is

  3. What They Do, And How The Money Works

  4. Who Runs It, And How To Reach Them

  5. The Money: Funding, Valuation, Runway

  6. Who Pays Them, And Who They Are Up Against

  7. Warning Bells

  8. Sources

    2 cited sources found

Plus the sections for what you are deciding, which you pick after ordering.

See a sample report

First screen of a real sample Full Report on EchoStar: the verdict, 17 sections, 63 cited sources, built 2026-10-21A real finished report, first screen. Opens in a new tab.

The full profile

Checking your access…

Is this you?

If you're behind Cardiosense, Inc.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.

Sourced from the filing index on sec.gov.

Follow this companyRSS

Tools for this story

Each opens in a new tab, filled in for Cardiosense, Inc.. With no account yet, you sign up free and land on the result.

On these startup lists

Healthcare and health tech startups

Share this page

Is this your company?

Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.

Cardiosense, Inc.: Raised $26.14M, Form D filed 2026-08-24
Share on LinkedIn Share on X Download image

Cite this page

Permanent URL: https://mentionfox.com/funding/cardiosense-inc-form-d-26000001
Last updated 2026-10-20
Primary record: SEC filing 1 · SEC filing 2
Cardiosense raised $26.14M — SEC Form D filing, August 2026. MentionFox, 2026-10-20. https://mentionfox.com/funding/cardiosense-inc-form-d-26000001